
This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.
Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Flatiron Assist. LeanTaas. DeepScribe. Most US oncologists were years into practice when these technology companies took their first steps, starting about 15 years ago—the same year the





